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Abstract
Background: Nocardia farcinica is one of the more recently identified species of the Nocardia genus. Nocardia
farcinica keratitis is a rare occurrence, with only eight previously reported cases. Semi-permeable rigid contact lens
use was associated with one of these reported cases. We report the first case of extended wear soft
contact-lens-related Nocardia farcinica keratitis and recommend a new treatment regime.
Findings: A 47-year-old lady presented with a right eye keratitis after wearing her extended wear soft contact
lenses for five continuous weeks. There was no history of trauma or swimming with contact lenses in. Empirical
ciprofloxacin and tobramycin eye drops were not tolerated due to ocular surface irritation on application; and
instead, empirical treatment was with chloramphenicol and fortified gentamicin 1.5 % eye drops. Corneal scrapings
grew Nocardia farcinica after 3 weeks—sensitive to amikacin and co-trimoxazole. Treatment was changed to
amikacin 2.5 % eye drops, resulting in partial resolution of the corneal infiltrates. Oral co-trimoxazole 160/800 mg
BD was added, due to cultured drug sensitivity and its high ocular penetration, with good results and a final right
eye best-corrected visual acuity of 6/5.
Conclusion: Nocardia farcinica keratitis should be considered in the differential diagnosis of contact-lens-related
keratitis. We report the first case occurring in association with extended wear soft contact lenses. Nocardia species
can mimic fungal and Acanthamoeba keratitis. Treatment with oral co-trimoxazole has not been previously
reported. This case demonstrates a role for co-trimoxazole in treating Nocardia farcinica keratitis based on cultured
drug sensitivities.
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Introduction
Nocardia species (sp.) are a rare cause of human ocular
infections [1–8]. Advances in laboratory techniques have
resulted in further speciation of the genus [2, 3]. Nocar-
dia farcinica is a newer species and has been implicated
in keratitis, endophthalmitis, and chorioretinitis [1–6].
Eight cases of Nocardia farcinica keratitis have been re-
ported in the literature, and only one has been associ-
ated with contact lens wear (semi-permeable rigid
contact lenses) [1]. We report the first case of extended
wear soft contact-lens-related Nocardia farcinica kera-
titis and recommend a new treatment regime.
Report
A 47-year-old Caucasian woman presented with a 2-day
history of a red, painful, photophobic right eye and
marked blepharospasm on a background of contact lens
wear. She wore her monthly disposable soft contact lenses
for five continuous weeks. There was a history of recent
gardening but no trauma, travel to remote areas, or swim-
ming whilst wearing contact lenses. Her only medication
was irbesartan for well-controlled hypertension.
On examination, unaided visual acuity in the right eye
at presentation was 6/18, improving to 6/9 with pinhole
correction. Best-corrected visual acuity (BCVA) in the
left eye was 6/9. The right eye was injected, with four
central satellite lesions (Fig. 1) and moderate anterior
chamber reaction (cells 3+; flare 1+; no hypopyon). The
vitreous was quiet and intraocular pressure was
14 mmHg on the right eye. Ocular examination of the
left eye was unremarkable. Corneal scrapings were taken
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and her contact lenses sent for microscopy, culture, and
sensitivities.
Treatment with ciprofloxacin 0.3 % eye drops hourly and
homatropine 2 % eye drops TDS right eye was com-
menced. The patient was non-compliant due to ocular sur-
face irritation from the drops. Antibiotic therapy was
changed to tobramycin 0.3 % eye drops hourly right eye
2 days post-presentation to improve compliance but was
again unsuccessful due to irritation from tobramycin. Four
days after presentation, the treatment was changed to
chloramphenicol minims hourly, fortified gentamicin 1.5 %
eye drops hourly, and atropine 1 % minims TDS right eye.
Ocular surface discomfort settled on this treatment regime.
Further right eye corneal scraping was performed.
After 1 week of treatment, the right eye’s unaided vis-
ual acuity reduced to light perception, improving to 6/18
with pinhole correction. Corneal oedema and inferior
keratitic precipitates had developed, and the satellite le-
sions had coalesced into a 4.7 × 3.8 mm wreath-like infil-
trate with surrounding stromal hyphae and a central
corneal epithelial defect. The posterior segment remained
uninvolved. The initial corneal scraping and contact lens
cultures revealed no pathogens. The second corneal scrap-
ing identified a Gram-positive aerobic Actinomyces only.
Treatment on hourly chloramphenicol 0.3 % minims and
gentamicin 1.5 % eye drops right eye continued until drug
sensitivities were available.
Following 3 weeks of culture, the second corneal scrap-
ing grew Nocardia farcinica (Fig. 2)—sensitive to co-
trimoxazole and amikacin, and resistant to cephalothin,
tobramycin, and ciprofloxacin. Sensitivities to chloram-
phenicol and gentamicin were not available from the
laboratory.
Treatment with prednisolone acetate eye drops six times
per day right eye was commenced after fungal pathogens
were not cultured. The patient remained on hourly chlor-
amphenicol 0.3 % minims and gentamicin 1.5 % eye drops
right eye for another 2 weeks. The keratitis remained
stable in this period, and the right eye pinhole vision fluc-
tuated between 6/36 and 6/18. The wreath-like infiltrate
and central epithelial defect did not change in size, and
the anterior chamber reaction reduced slightly.
The antibiotic regime was subsequently changed to ami-
kacin 2.5 % eye drops hourly right eye based on drug sen-
sitivities. The patient remained on atropine 1 % minims
QID and prednisolone acetate eye drops six times per day
right eye. Within 1 week on this regime, an improvement
occurred, with less conjunctival injection and decreased
density of the wreath-like infiltrate. However, the size of
the infiltrate and central epithelial defect showed no
change. In consultation with the Infectious Diseases Unit,
oral co-trimoxazole 160/800 mg BD (trimethoprim-sulfa-
methoxazole) was added based on the cultured drug sensi-
tivities and its high ocular penetration [9]. Unfortunately,
given the regional location of the treating hospital, poly-
myxin B and trimethoprim ophthalmic solution was not
available from the pharmacy. The wreath-like infiltrate
Fig. 1 Satellite lesions at presentation
Fig. 2 a Gram stain of Nocardia farcinica showing Gram-positive rod-shaped bacteria. b Modified Ziehl-Neelsen stain showing partial acid-fast reaction
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and epithelial defect resolved leaving a dense central cor-
neal scar over the subsequent 3 weeks. The right eye
BCVA was now hand movements at 3 m. The amikacin
2.5 % eye drops was tapered weekly, prednisolone acetate
eye drops was increased to two hourly, and oral co-
trimoxazole 160/800 mg BD and atropine 1 % eye drops
were ceased.
Clinical improvement occurred over the next month, and
the right eye pinhole vision was now 6/18. However, the
patient reported 2 days of redness, ocular surface discom-
fort, and photophobia whilst on amikacin 2.5 % eye drops
TDS and prednisolone acetate eye drops six times per
day. The right eye pinhole vision reduced to 6/60. A
new epithelial defect and satellite lesion had developed su-
perior to the corneal scar (Fig. 3). Subsequently, amikacin
2.5 % eye drops was increased to hourly, oral co-
trimoxazole 160/800 mg BD was restarted, and prednisol-
one acetate eye drops was ceased.
The new satellite lesion did not form a wreath-like in-
filtrate as had occurred previously. The epithelial defect
required 3 weeks of amikacin 2.5 % eye drops hourly
right eye and oral co-trimoxazole 160/800 mg BD before
healing. Prednisolone acetate eye drops was continued
by the patient to relieve ocular discomfort against ad-
vice. Once the epithelial defect had healed, oral co-
trimoxazole was ceased and amikacin eye drops was
tapered.
Prednisolone acetate eye drops had been successfully
ceased, and there were no signs of relapse on the taper-
ing dose of amikacin eye drops over the course of the
next 8 weeks. At final review, the right eye BCVA was 6/
5 with a faint central wreath-like anterior stromal scar
and no anterior chamber activity.
Discussion
Nocardia sp. are Gram-positive, partially acid-fast, aerobic
rod-shaped bacteria that rarely cause systemic disease due
to low virulence [1–8, 10]. Advances in laboratory speci-
ation techniques have lead to the discovery of newer spe-
cies, with identification of several other Nocardia sp.
capable of infiltrating the cornea [2, 3]. The discovery of
Nocardia farcinica is important because of its resistance to
several common topical ophthalmic antibiotics [1, 10–13].
Most reported cases of intraocular Nocardia farcinica
infection have occurred secondary to haematogenous
spread from a primary pulmonary infectious focus in im-
munocompromised individuals [3–6, 10]. There have been
two reported cases of post-operative and post-traumatic
endophthalmitis caused from Nocardia farcinica [5, 6].
The genus Nocardia is saprophytes [1–8, 10]. There
have been eight documented cases of Nocardia farcinica
keratitis [1, 2]. Seven of these cases were reported in a
South Indian study, and all occurred secondary to trauma
with organic matter [2]. The remaining case of Nocardia
farcinica keratitis was contact-lens-related, occurring after
semi-permeable rigid contact lenses were cleaned in un-
chlorinated rainwater [1]. We report the first case of
Nocardia farcinica keratitis occurring with the use of ex-
tended wear soft contact lenses.
Extended wear soft contact lenses are a well-
documented major risk factor for microbial keratitis, due
to their interference with the natural defence properties of
the ocular surface [14]. It has not commonly been reported
as a cause of Nocardia sp. keratitis [1, 2, 15, 16]. However,
the larger studies on Nocardia sp. keratitis have been con-
ducted in less urbanised areas, leaving the potential for
population bias [2, 16]. Our case adds to the small number
of Nocardia sp. keratitis cases where contact lens wear
was the most likely predisposing factor [1, 15].
Nocardia sp. keratitis has been reported as presenting
with patchy anterior stromal infiltrates—occasionally with
feathery borders, stromal hyphae, and wreath-like infil-
trates [1, 2, 6, 15, 16]. Keratitic precipitates and endothe-
lial ring deposits have also been documented [2]. The
presentation of this case was consistent with these reports
but was unusual as there was no history of contamination
with plant matter as has been described in other cases of
Nocardia farcinica keratitis [1, 2]. Nocardia sp. keratitis
mimics the presentation of fungal keratitis and could mis-
lead clinicians to commence empirical treatment with an-
tifungal therapy [1, 2, 15, 17].
Acanthamoeba keratitis is included in the differential
diagnosis of Nocardia farcinica keratitis, as both present
with marked blepharospasm, photophobia, and wreath-
like infiltrates [1, 2]. There has previously been one
Fig. 3 Reactivation—new satellite lesions; faint stromal scar at old
infection site
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report of Nocardia asteroides keratitis being successfully
treated with polyhexamethylene biguanide, demonstrat-
ing that this pool disinfectant could be used as empirical
treatment in Nocardia sp. keratitis [2, 15].
Ciprofloxacin 0.3 % eye drops are widely regarded as
an empirical treatment for contact-lens-related keratitis
due to its efficacy against common causative pathogens
[14]. This patient was empirically treated with ciproflox-
acin eye drops, and then tobramycin eye drops, another
agent commonly used to treat contact lens keratitis [14].
The strain of Nocardia farcinica grown from this pa-
tient’s corneal scrapings was resistant to ciprofloxacin
and tobramycin. A South Indian study looking at the
antibiotic sensitivities of four different Nocardia sp. (N.
asteroides, N. farcinica, N. cyriageorgica, and N. otitidis-
caviarum) found that Nocardia farcinica was the only
species to display complete resistance to gentamicin,
tobramycin, and cefotaxime but found that all seven
cases were sensitive to ciprofloxacin [18].
Previous reports have found a high level of resistance
in Nocardia farcinica to both chloramphenicol and gen-
tamicin [1, 16, 19, 20]. This highlights the importance of
testing sensitivities to all potential ophthalmic antibi-
otics, especially in atypical clinical presentations. This
is particularly relevant with Nocardia farcinica, which
is resistant to many common topical ophthalmic anti-
biotic preparations [1, 10, 11, 15–20]. There have
been no reports of amikacin resistance in Nocardia farci-
nica [1, 2, 11, 12, 19, 21, 22]. There have been a few re-
ported cases in the general medical literature of Nocardia
farcinica resistance to co-trimoxazole [4, 10, 16, 17].
The role of systemic antibiotics in Nocardia sp. keratitis
has not been documented [2, 16]. In this patient, reso-
lution of the epithelial defect and clearing of the corneal
infiltrates only occurred after the commencement of oral
co-trimoxazole. The high ocular penetration and minimal
side effect profile of co-trimoxazole make it beneficial as
an adjunct to topical treatment in Nocardia sp. keratitis,
based on cultured drug sensitivities [9].
Clinical reactivation of infection occurred with topical
steroid use after the epithelial defect had commenced
scarring. Reactivation with steroid use in Nocardia sp.
has been highlighted before, and they should be used
cautiously in Nocardia sp. infections [1, 2].
Nocardia farcinica is a rare cause of keratitis and should
be considered as differential diagnoses of contact-lens-
related keratitis, post-traumatic keratitis, and clinical pic-
tures suggestive of fungal and Acanthamoeba keratitis. This
is the first reported case of Nocardia farcinica keratitis oc-
curring secondary to extended wear soft contact lenses.
Nocardia sp. keratitis is a challenge to treat empirically due
to high levels of resistance to common topical ophthalmic
antibiotics. Despite delayed treatment in this case, the kera-
titis responded well to a combination of amikacin 2.5 % eye
drops and oral co-trimoxazole 160/800 mg BD and long
duration of therapy, with a final right eye BCVA of 6/5.
This case demonstrates the effectiveness of oral co-
trimoxazole160/800 mg BD in treating Nocardia farci-
nica keratitis, and we recommend considering it as an
adjunct treatment based on cultured drug sensitivities.
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